RESUMEN
RESUMEN El objetivo fue investigar el comportamiento del malondialdehido (MDA), biomarcador de estrés oxidativo, a grandes altitudes (3500-4200 m de altitud). Se realizó un estudio exploratorio en 91 sujetos de las ciudades de La Paz y El Alto seleccionados a través de una encuesta y examen clínico; la determinación de MDA se realizó con una técnica colorimétrica. Las medidas de tendencia central, dispersión y porcentajes se usaron para la descripción de datos, la prueba de Mann Whitney y Kruscal Wallis para explorar diferencias entre varones y mujeres, grupo etario y altitud. La mediana de concentración de MDA fue de 4,1 µmol/L (RIC 2,4-5,4), la mayor concentración se encontró en mayores de 40 años. El valor de la media encontrada es mayor que los referidos para el nivel del mar y supone la influencia de la hipoxia sobre los valores del MDA, sin embargo, no se encontraron diferencias entre sexo y grupos etarios.
ABSTRACT The objective of this study was to determine the levels of malondialdehyde (MDA), an oxidative stress biomarker, in individuals living at high altitudes (3500-4200 m). This exploratory study evaluated 91 subjects from La Paz and El Alto using a questionnaire and clinical examination. MDA levels were measured using a colorimetric technique. Measures of central tendency, dispersion, and percentages were used to describe data, and the Mann-Whitney test and Kruskal-Wallis test were used to assess differences between the sexes, age groups, and altitudes. The median concentration of MDA was 4.1 μmol/L (RIC 2.4-5.4) and the highest concentration of MDA was found in individuals older than 40 years. The average MDA levels were higher than those found at sea level, a result we believe is due to the effect of hypoxia. However, there were no differences in the MDA levels between the sexes or age groups.
Asunto(s)
Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Estrés Oxidativo , Altitud , Malondialdehído/sangre , Bolivia , Biomarcadores/sangre , Salud UrbanaRESUMEN
The objective of this study was to determine the levels of malondialdehyde (MDA), an oxidative stress biomarker, in individuals living at high altitudes (3500-4200 m). This exploratory study evaluated 91 subjects from La Paz and El Alto using a questionnaire and clinical examination. MDA levels were measured using a colorimetric technique. Measures of central tendency, dispersion, and percentages were used to describe data, and the Mann-Whitney test and Kruskal-Wallis test were used to assess differences between the sexes, age groups, and altitudes. The median concentration of MDA was 4.1 µmol/L (RIC 2.4-5.4) and the highest concentration of MDA was found in individuals older than 40 years. The average MDA levels were higher than those found at sea level, a result we believe is due to the effect of hypoxia. However, there were no differences in the MDA levels between the sexes or age groups.
El objetivo fue investigar el comportamiento del malondialdehido (MDA), biomarcador de estrés oxidativo, a grandes altitudes (3500-4200 m de altitud). Se realizó un estudio exploratorio en 91 sujetos de las ciudades de La Paz y El Alto seleccionados a través de una encuesta y examen clínico; la determinación de MDA se realizó con una técnica colorimétrica. Las medidas de tendencia central, dispersión y porcentajes se usaron para la descripción de datos, la prueba de Mann Whitney y Kruscal Wallis para explorar diferencias entre varones y mujeres, grupo etario y altitud. La mediana de concentración de MDA fue de 4,1 µmol/L (RIC 2,4-5,4), la mayor concentración se encontró en mayores de 40 años. El valor de la media encontrada es mayor que los referidos para el nivel del mar y supone la influencia de la hipoxia sobre los valores del MDA, sin embargo, no se encontraron diferencias entre sexo y grupos etarios.
Asunto(s)
Altitud , Malondialdehído/sangre , Estrés Oxidativo , Adolescente , Adulto , Biomarcadores/sangre , Bolivia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Salud Urbana , Adulto JovenRESUMEN
INTRODUCTION: There are no medical publications with economic analysis of rheumatoid arthritis patients (RA) from Argentina are lacking. The objective of the present study is to determine the direct cost and its breakdown in patients with RA. MATERIAL AND METHODS: Fifty-two patients who met the American College of Rheumatology RA criteria were included. Direct cost was calculated over a follow-up period of 6 months during year 2001. Variables were analyzed with Student's T test, Mann-Whitney U Test, c' or ANOVA as corresponded. P values < 0.05 were considered significant. RESULTS: The mean monthly home income was $426.6 SD 272. The mean half-yearly direct costs was $677.5 SD 376.2. The components of the direct cost were identified and the mean for medication cost was $606.7 (89%), for lab tests was $45.5 (7%), for medical attention $12.5 (2%) and other costs $2.4. No differences in total cost or in medication cost were found when compared considering age, evolution time of RA or HAQ scores. CONCLUSION: Half-yearly direct cost in RA is excessively high considering the monthly mean income of the patients being analyzed. The cost of medication was the principal component of the direct cost.
Asunto(s)
Artritis Reumatoide/economía , Costos de Hospital/estadística & datos numéricos , Hospitales Universitarios , Análisis de Varianza , Argentina , Artritis Reumatoide/terapia , Femenino , Estudios de Seguimiento , Humanos , Masculino , Estadísticas no Paramétricas , Factores de TiempoRESUMEN
INTRODUCTION: There are no medical publications with economic analysis of rheumatoid arthritis patients (RA) from Argentina are lacking. The objective of the present study is to determine the direct cost and its breakdown in patients with RA. MATERIAL AND METHODS: Fifty-two patients who met the American College of Rheumatology RA criteria were included. Direct cost was calculated over a follow-up period of 6 months during year 2001. Variables were analyzed with Students T test, Mann-Whitney U Test, c or ANOVA as corresponded. P values < 0.05 were considered significant. RESULTS: The mean monthly home income was $426.6 SD 272. The mean half-yearly direct costs was $677.5 SD 376.2. The components of the direct cost were identified and the mean for medication cost was $606.7 (89 per cent), for lab tests was $45.5 (7 per cent), for medical attention $12.5 (2 per cent) and other costs $2.4. No differences in total cost or in medication cost were found when compared considering age, evolution time of RA or HAQ scores. CONCLUSION: Half-yearly direct cost in RA is excessively high considering the monthly mean income of the patients being analyzed. The cost of medication was the principal component of the direct cost. (AU)
Asunto(s)
Humanos , Masculino , Femenino , Costos de Hospital/estadística & datos numéricos , Artritis Reumatoide/economía , Hospitales Universitarios , Estudios de Seguimiento , Factores de Tiempo , Análisis de Varianza , Argentina , Artritis Reumatoide/terapiaRESUMEN
INTRODUCTION: There are no medical publications with economic analysis of rheumatoid arthritis patients (RA) from Argentina are lacking. The objective of the present study is to determine the direct cost and its breakdown in patients with RA. MATERIAL AND METHODS: Fifty-two patients who met the American College of Rheumatology RA criteria were included. Direct cost was calculated over a follow-up period of 6 months during year 2001. Variables were analyzed with Student's T test, Mann-Whitney U Test, c' or ANOVA as corresponded. P values < 0.05 were considered significant. RESULTS: The mean monthly home income was $426.6 SD 272. The mean half-yearly direct costs was $677.5 SD 376.2. The components of the direct cost were identified and the mean for medication cost was $606.7 (89 per cent), for lab tests was $45.5 (7 per cent), for medical attention $12.5 (2 per cent) and other costs $2.4. No differences in total cost or in medication cost were found when compared considering age, evolution time of RA or HAQ scores. CONCLUSION: Half-yearly direct cost in RA is excessively high considering the monthly mean income of the patients being analyzed. The cost of medication was the principal component of the direct cost.
Asunto(s)
Humanos , Masculino , Femenino , Artritis Reumatoide , Costos de Hospital/estadística & datos numéricos , Hospitales Universitarios , Análisis de Varianza , Argentina , Artritis Reumatoide , Estudios de Seguimiento , Factores de TiempoRESUMEN
INTRODUCTION: There are no medical publications with economic analysis of rheumatoid arthritis patients (RA) from Argentina are lacking. The objective of the present study is to determine the direct cost and its breakdown in patients with RA. MATERIAL AND METHODS: Fifty-two patients who met the American College of Rheumatology RA criteria were included. Direct cost was calculated over a follow-up period of 6 months during year 2001. Variables were analyzed with Students T test, Mann-Whitney U Test, c or ANOVA as corresponded. P values < 0.05 were considered significant. RESULTS: The mean monthly home income was $426.6 SD 272. The mean half-yearly direct costs was $677.5 SD 376.2. The components of the direct cost were identified and the mean for medication cost was $606.7 (89
), for lab tests was $45.5 (7
), for medical attention $12.5 (2
) and other costs $2.4. No differences in total cost or in medication cost were found when compared considering age, evolution time of RA or HAQ scores. CONCLUSION: Half-yearly direct cost in RA is excessively high considering the monthly mean income of the patients being analyzed. The cost of medication was the principal component of the direct cost.
RESUMEN
Se presenta un método simple y rápido, a la vez que seguro y efectivo, para elevar percutáneamente el hundimiento cerrado de la bóveda craneal del recién nacido y del lactante menor, utilizando un gancho metálico fabricado a partir de una aguja de punción raquídea.